IÁInés Álvarez-Miguel

Inés Álvarez-Miguel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Inés Álvarez-Miguel has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ca-triazine phosphonate metal–organic framework as fungicide active packaging

    by Rubén Serrano-Nieto, Miriam Abán, Marta E. G. Mosquera, Tania Hidalgo, Claire Ayala, Inés Álvarez-Miguel, Patricia Horcajada

    A novel three-dimensional metal–organic framework (MOF) based on the biocompatible/bioactive, earth-abundant calcium and the photoactive triazine triphosphonate ligand has been hydrothermally synthesised and fully characterised (XRD, FTIR, TGA, SEM, etc.). Denoted as IEF-32 (IEF stands for the IMDEA Energy Framework), its crystal structure was unveiled by single-crystal X-ray diffraction, exhibiting free P–OH groups in two coordination modes (–PO3H2 and –PO3H) and acid unsaturated metal sites. This robust structure shows high thermal and chemical stability (in several catalytically-relevant organic solvents and water, pH = 3 to 12). Furthermore, this study presents the first proof of concept for employing a Ca phosphonate MOF as an antifungal and preservative agent in active packaging. Specifically, IEF-32 effectively preserved grapes, extending their shelf life to one month under fungal spoilage and ripening conditions (relative humidity 80%, 21 °C) while retaining its structural and chemical integrity. Finally, in vitro studies confirmed the biosafety of IEF-32 in intestinal and pulmonary cells, opening new avenues for the implementation of Ca-based P-MOFs in sustainable food preservation technologies.


  • A Potential 3‐in‐1 Combined AntiSARS‐CoV‐2 Therapy Using Pulmonary MIL‐100(Fe) Formulation

    by Beatrice Fodor, Inés Álvarez‐Miguel, Catalina Biglione, Guillermo G. López, África González‐Fernández, Fabrice Salles, Tania Hidalgo, Patricia Horcajada

    The emergence and rapid propagation of infectious diseases, including the COVID‐19 pandemic, has evidenced the vulnerabilities in global health surveillance, the ease of transmission, and the imperative need for effective treatments. In this context, nanomedicines based on metal–organic frameworks (MOFs) have garnered great relevance as promising drug delivery platforms in a large range of complex diseases (e.g., cancer, and infections). However, most research has focused on sensing with scarce examples in antiviral therapies. Hence, here a pioneer combined 3‐in‐1 effect anti‐COVID pulmonary multitherapy based on the mesoporous iron(III) carboxylate MIL‐100(Fe) nanoparticles is proposed, with the proven intrinsic MOF effect, associated with favipiravir drug into their porosity and heparin on their external surface. A significant antiviral effect against a real scenario of COVID‐19 infection is demonstrated (≈70% inhibition), ensuring a suitable cellular viability. Further, a convenient pulmonary formulation is prepared based on mannitol‐based microspheres, testing its safety and biodistribution in healthy mice. No significant side effects are observed, reaching successfully the deep lungs, emphasizing a reduced immunological response compared to their controls. Therefore, these promising results open new horizons for future (pre)clinical trials targeting challenging infectious/pulmonary pathologies, enhancing the feasibility of designing customized therapeutic MOF platforms.


  • Open Access

    The P2Y6 Receptor as a Potential Keystone in Essential Hypertension

    by Nuria Daghbouche-Rubio, Inés Álvarez-Miguel, Victor Alejandro Flores, Jorge Rojo-Mencía, Manuel Navedo, Madeleine Nieves-Citrón, Pilar Cidad, M Teresa Pérez-García, José R López-López

    Essential hypertension (HT) is a highly prevalent cardiovascular disease of unclear physiopathology. Pharmacological studies suggest that purinergic P2Y6 receptors (P2ry6) play important roles in cardiovascular function and may contribute to angiotensin II (AgtII) pathophysiological effects. Here, we tested the hypothesis that functional coupling between P2ry6 and AgtII receptors mediates altered vascular reactivity in HT. For this, a multipronged approach was implemented using mesenteric vascular smooth muscle cells (VSMCs) and arteries from Blood Pressure Normal (BPN) and Blood Pressure High (BPH) mice. Differential transcriptome profiling of mesenteric artery VSMCs identified P2ry6 purinergic receptor mRNA as one of the top upregulated transcripts in BPH. P2Y receptor activation elicited distinct vascular responses in mesenteric arteries from BPN and BPH mice. Accordingly, 10 µm UTP produced a contraction close to half-maximal activation in BPH arteries but no response in BPN vessels. AgtII-induced contraction was also higher in BPH mice despite having lower AgtII receptor type-1 (Agtr1) expression and was sensitive to P2ry6 modulators. Proximity ligation assay and super-resolution microscopy showed closer localization of Agtr1 and P2ry6 at/near the membrane of BPH mice. This proximal association was reduced in BPN mice, suggesting a functional role for Agtr1-P2ry6 complexes in the hypertensive phenotype. Intriguingly, BPN mice were resistant to AgtII-induced HT and showed reduced P2ry6 expression in VSMCs. Altogether, results suggest that increased functional coupling between P2ry6 and Agtr1 may contribute to enhanced vascular reactivity during HT. In this regard, blocking P2ry6 could be a potential pharmacological strategy to treat HT.


  • Open Access

    Metal–Organic Frameworks: Unconventional Nanoweapons against COVID

    by Inés Álvarez-Miguel, Beatrice Fodor, Guillermo G. López, Catalina Biglione, Erik Svensson Grape, A. Ken Inge, Tania Hidalgo, Patricia Horcajada

    The SARS-CoV-2 (COVID-19) pandemic outbreak led to enormous social and economic repercussions worldwide, felt even to this date, making the design of new therapies to combat fast-spreading viruses an imperative task. In the face of this, diverse cutting-edge nanotechnologies have risen as promising tools to treat infectious diseases such as COVID-19, as well as challenging illnesses such as cancer and diabetes. Aside from these applications, nanoscale metal-organic frameworks (nanoMOFs) have attracted much attention as novel efficient drug delivery systems for diverse pathologies. However, their potential as anti-COVID-19 therapeutic agents has not been investigated. Herein, we propose a pioneering anti-COVID MOF approach by studying their potential as safe and intrinsically antiviral agents through screening various nanoMOF. The iron(III)-trimesate MIL-100 showed a noteworthy antiviral effect against SARS-CoV-2 at the micromolar range, ensuring a high biocompatibility profile (90% of viability) in a real infected human cellular scenario. This research effectively paves the way toward novel antiviral therapies based on nanoMOFs, not only against SARS-CoV-2 but also against other challenging infectious and/or pulmonary diseases.


  • Copper complexes for the promotion of iminopyridine ligands derived from β-alanine and self-aldol additions: relaxivity and cytotoxic properties

    by Lucía Álvarez-Miguel, Inés Álvarez-Miguel, Jose M. Martín-Álvarez, Celedonio M. Álvarez, Guillaume Rogez, Raúl García-Rodríguez, Daniel Miguel

    The template effect in K2(N,O) chelated Cu(ii) complexes can promote C–C or C–N coupling products.


  • Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension

    by Inés Álvarez‐Miguel, Pilar Cidad, M. Teresa Pérez‐García, José Ramón López‐López

    Key points: Canonical transient receptor potential (TRPC)3 and TRPC6 channels of vascular smooth muscle cells (VSMCs) mediate stretch‐ or agonist‐induced cationic fluxes, contributing to membrane potential and vascular tone. Native TRPC3/C6 channels can form homo‐ or heterotetrameric complexes, which can hinder individual TRPC channel properties. The possibility that the differences in their association pattern may change their contribution to vascular tone in hypertension is unexplored. Functional characterization of heterologously expressed channels showed that TRPC6‐containing complexes exhibited Pyr3/Pyr10‐sensitive currents, whereas TRPC3‐mediated currents were blocked by anti‐TRPC3 antibodies. VSMCs from hypertensive (blood pressure high; BPH) mice have larger cationic basal currents insensitive to Pyr10 and sensitive to anti‐TRPC3 antibodies. Consistently, myography studies showed a larger Pyr3/10‐induced vasodilatation in BPN (blood pressure normal) mesenteric arteries. We conclude that the increased TRPC3 channel expression in BPH VSMCs leads to changes in TRPC3/C6 heteromultimeric assembly, with a higher TRPC3 channel contribution favouring depolarization of hypertensive VSMCs. Increased vascular tone in essential hypertension involves a sustained rise in total peripheral resistance. A model has been proposed in which the combination of membrane depolarization and higher L‐type Ca2+ channel activity generates augmented Ca2+ influx into vascular smooth muscle cells (VSMCs), contraction and vasoconstriction. The search for culprit ion channels responsible for membrane depolarization has provided several candidates, including members of the canonical transient receptor potential (TRPC) family. TRPC3 and TRPC6 are diacylglycerol‐activated, non‐selective cationic channels contributing to stretch‐ or agonist‐induced depolarization. Conflicting information exists regarding changes in TRPC3/TRPC6 functional expression in hypertension. However, although TRPC3‐TRPC6 channels can heteromultimerize, the possibility that differences in their association pattern may change their functional contribution to vascular tone is largely unexplored. We probe this hypothesis using a model of essential hypertension (BPH mice; blood pressure high) and its normotensive control (BPN mice; blood pressure normal). First, non‐selective cationic currents through homo‐ and heterotetramers recorded from transfected Chinese hamster ovary cells indicated that TRPC currents were sensitive to the selective antagonist Pyr10 only when TRPC6 was present, whereas intracellular anti‐TRPC3 antibody selectively blocked TRPC3‐mediated currents. In mesenteric VSMCs, basal and agonist‐induced currents were more sensitive to Pyr3 and Pyr10 in BPN cells. Consistently, myography studies showed a larger Pyr3/10‐induced vasodilatation in BPN mesenteric arteries. mRNA and protein expression data supported changes in TRPC3 and TRPC6 proportions and assembly, with a higher TRPC3 channel contribution in BPH VSMCs that could favour cell depolarization. These differences in functional and pharmacological properties of TRPC3 and TRPC6 channels, depending on their assembly, could represent novel therapeutical opportunities.


  • Open Access

    Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation

    by Gema Lordén, Itziar Sanjuán-García, Nagore de Pablo, Clara Meana, Inés Alvarez-Miguel, M. Teresa Pérez-García, Pablo Pelegrín, Jesús Balsinde, María A. Balboa

    Mutations in human LPIN2 produce a disease known as Majeed syndrome, the clinical manifestations of which are ameliorated by strategies that block IL-1β or its receptor. However the role of lipin-2 during IL-1β production remains elusive. We show here that lipin-2 controls excessive IL-1β formation in primary human and mouse macrophages by several mechanisms, including activation of the inflammasome NLRP3. Lipin-2 regulates MAPK activation, which mediates synthesis of pro–IL-1β during inflammasome priming. Lipin-2 also inhibits the activation and sensitization of the purinergic receptor P2X7 and K+ efflux, apoptosis-associated speck-like protein with a CARD domain oligomerization, and caspase-1 processing, key events during inflammasome activation. Reduced levels of lipin-2 in macrophages lead to a decrease in cellular cholesterol levels. In fact, restoration of cholesterol concentrations in cells lacking lipin-2 decreases ion currents through the P2X7 receptor, and downstream events that drive IL-1β production. Furthermore, lipin-2–deficient mice exhibit increased sensitivity to high lipopolysaccharide doses. Collectively, our results unveil lipin-2 as a critical player in the negative regulation of NLRP3 inflammasome.


  • Open Access

    Molecular Determinants of Kv1.3 Potassium Channels-induced Proliferation

    by Laura Jiménez-Pérez, Pilar Cidad, Inés Álvarez-Miguel, Alba Santos-Hipólito, Rebeca Torres-Merino, Esperanza Alonso, Miguel Ángel de la Fuente, José Ramón López-López, M. Teresa Pérez-García